Home Contact us Site Map
milestones
 
  • USFDA certified the API facility at Tarapur and Dombivli Intermediate are acceptable
  • EDQM approved CEPs for Pyrazinamide, Isoniazid and Zopiclone in February 2012.
  • WHO Geneva approved APIs - Pyrazinamide, Isoniazid, Artemether and Lumefrantine in May 2012.
  • FDA - Konkan Division, Maharashtra certified that Manufacturing Unit at Tarapur holds Manufacturing License under the provision of Drugs and Cosmetics Act, 1940 and observed good manufacturing practices under provision of Drugs and Cosmetics Rules, 1945.
  • Filed 14 USDMF
  • Filed 4 EDMF with EDQM
  • Filed 5 DMFs with Health Canada
  • ISO 9001:2008 certification from Bureau Veritas Certification valid until Sept 2015 (original approval Sept 2006)
  • ISO 14001:2004 certification from Bureau Veritas Certification valid until July 2013 (original approval Oct 2007)
  • Recognition from National Safety Council (MC) Certificate for achieving lowest accident frequency rate (2007 & 2008); Certificate of merit (2009, 2010 & 2011)
  • IDMA Quality Excellence Award (Silver) in 2007.
  • Department of Scientific & Industrial Research, Govt. of India, approved our R & D Centre; approval valid till March 2015.
  • Zonal Joint Director General of Foreign Trade, Ministry of Commerce and Industry, certified Calyx as Star Export House.
 











 
copyright © Calyx Chemicals & Pharmaceuticals Ltd.